| Model Number |
ETLW1610C146E |
| Medical Device Problem Code |
Activation, Positioning or Separation Problem (2906)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
12/30/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Additional information received; it was reported that there was a failure of the deployment mechanism of the limbs.This did not result in any untoward event.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
B5; additional information received: it was reported that when attempting to deploy the device, when the handle was rotated the sheath did not pull back but the entire device pushed upwards.After this, the device was looked at on the back table and it was thought it may be a packaging problem and the device was defective.The device was attempted to be used per the ifu.The replacement device performed as expected.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
An endurant ii stent graft was intended to be implanted during the endovascular treatment of an aaa.It was reported that during the index procedure the stent graft did not deploy.It was removed and replaced with another device.No cause was provided.No additional clinical sequalae were provided and the patient is fine.
|
| |
|
Search Alerts/Recalls
|